1. Home
  2. HRMY vs INOD Comparison

HRMY vs INOD Comparison

Compare HRMY & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$35.24

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$56.99

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
INOD
Founded
2017
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2020
1993

Fundamental Metrics

Financial Performance
Metric
HRMY
INOD
Price
$35.24
$56.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
3
Target Price
$50.56
$91.67
AVG Volume (30 Days)
934.4K
1.5M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
50.44
62.46
EPS
3.17
1.01
Revenue
$825,944,000.00
$238,467,000.00
Revenue This Year
$20.68
$48.07
Revenue Next Year
$15.93
$24.55
P/E Ratio
$11.14
$56.93
Revenue Growth
21.13
73.57
52 Week Low
$25.52
$26.41
52 Week High
$40.93
$93.85

Technical Indicators

Market Signals
Indicator
HRMY
INOD
Relative Strength Index (RSI) 71.09 41.54
Support Level $32.77 $49.71
Resistance Level $36.20 $57.30
Average True Range (ATR) 1.11 4.21
MACD 0.17 0.03
Stochastic Oscillator 81.04 32.34

Price Performance

Historical Comparison
HRMY
INOD

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

Share on Social Networks: